Sex and Gender Differences in Cancers of the Genitourinary Tract: The Need to Consider Immune Divergence.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34750036.
- Also identified by DOI 10.1016/j.eururo.2021.10.026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Delineating the processes of immune response underlying sexual dimorphism in cancers of the genitourinary tract will improve outcomes from immunotherapy treatment.
Medical subject headings
- Neoplasms
- Sex Characteristics